SCHEMBL4533680

SCHEMBL4533680

CO[Si](CCCCCCCCCCCCCCCCCCCCCCI)(OC)OC

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4529372 1.00 LMNA (0.42) LMNA
SCHEMBL4537162 1.00 LMNA (0.42) LMNA
SCHEMBL4535705 1.00 LMNA (0.42) LMNA
SCHEMBL4535982 1.00 LMNA (0.42) LMNA
SCHEMBL4539257 1.00 LMNA (0.42) LMNA
SCHEMBL4524630 1.00 LMNA (0.42) LMNA
SCHEMBL4531323 1.00 LMNA (0.42) LMNA
SCHEMBL4531708 1.00 LMNA (0.42) LMNA
SCHEMBL4519340 1.00 LMNA (0.42) LMNA
SCHEMBL4524415 1.00 LMNA (0.42) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090123516-A1 DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS-THERAPEUTIC SAMS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2009-05-14 US disclosed
WO-2007019478-A2 DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS - THERAPEUTIC SAMS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2007-02-15 WO disclosed